Australia markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.44-0.45 (-4.13%)
At close: 04:00PM EST
10.52 +0.08 (+0.77%)
After hours: 07:56PM EST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-1,321,974
-1,743,751
-418,259
-132,694
Depreciation & amortisation
25,504
12,661
4,885
5,676
Stock-based compensation
134,694
183,626
128,035
17,048
Change in working capital
31,108
1,733,618
12,017
-24,018
Accounts receivable
-230,161
-192,265
-422,689
-
Other working capital
-727,814
265,460
-97,163
-138,480
Other non-cash items
108,994
136,792
230,781
6,293
Net cash provided by operating activities
-640,529
322,946
-42,541
-136,623
Cash flows from investing activities
Investments in property, plant and equipment
-87,285
-57,486
-54,622
-1,857
Acquisitions, net
-
0
-165,516
-
Purchases of investments
0
-2,167
-363,202
-17,484
Sales/maturities of investments
0
159,807
205,562
39,500
Net cash used for investing activities
-87,285
100,154
-377,778
38,492
Cash flows from financing activities
Debt repayment
-109,935
-127,907
-96,065
0
Common stock issued
179,385
564,859
875,623
97,392
Other financing activities
-
-
-39,087
-
Net cash used provided by (used for) financing activities
72,837
461,713
984,762
98,384
Net change in cash
-653,804
879,521
566,558
221
Cash at beginning of period
1,946,826
648,738
82,180
81,959
Cash at end of period
1,291,849
1,528,259
648,738
82,180
Free cash flow
Operating cash flow
-640,529
322,946
-42,541
-136,623
Capital expenditure
-87,285
-57,486
-54,622
-1,857
Free cash flow
-727,814
265,460
-97,163
-138,480